innovative product
Schematic diagram of product preparation and use
TareSphere™ Yttrium-90 Carbon Microsphere
Investigational radioactive microsphere for cancer treatment using minimally invasive procedures.
Phase Ill pivotal trial in hepatocellular carcinoma in China
Phase I/II trial in pancreatic cancer in China
Advantages and characteristics
NRT holds full IP ownership and vertically integrates isotope-to-drug manufacturing.
Reactor-independent production, rapid radiolabeling for just-in-time therapeutic deployment.
The carbon-engineered matrix optimizesY-90 adsorption and maximize stability.
Optimized microsphere density achieves comprehensive tumor coverage.
Dual-shielded design prioritizes physician safety by reducing occupational radiation exposure during clinical handling.
Product schematic diagram
